Enel P, Charrel J, Larher M P, Reviron D, Manuel C, San Marco J L
Public Health Department, Faculté de Medecine, Marseille, France.
Eur J Epidemiol. 1991 Mar;7(2):147-53. doi: 10.1007/BF00237358.
At present questions are being asked world-wide about the risk of the AIDS epidemic. The discovery of an anti-HIV vaccine has become an urgent priority, but it also raises a number of sensitive questions. Ethical problems in this field are particularly delicate, since the perspectives of individual health and public health do not seem to coincide. Our research team conducted a review of more than 400 articles on the ethical problems raised by AIDS. We concentrated particularly on the ethical and legal issues raised by research on anti-HIV vaccine. These problems fall into three main categories: therapeutic assays, which must be controlled by a strict agreement defined by international norms; manufacture of the future vaccine, raising legal difficulties which must be faced and solved now; distribution of the vaccine to the population, which should be conducted on a general basis, i.e. it should be offered to all individuals and not only to risk groups.
目前,全球都在关注艾滋病疫情的风险。研发抗HIV疫苗已成为当务之急,但这也引发了一些敏感问题。该领域的伦理问题尤为棘手,因为个人健康和公共卫生的观点似乎并不一致。我们的研究团队对400多篇关于艾滋病引发的伦理问题的文章进行了综述。我们特别关注了抗HIV疫苗研究引发的伦理和法律问题。这些问题主要分为三大类:治疗性检测,必须由国际规范定义的严格协议进行管控;未来疫苗的生产,引发了必须立即面对和解决的法律难题;向公众分发疫苗,应该在普遍基础上进行,即应提供给所有个体,而不仅仅是高危群体。